Concepedia

Publication | Open Access

1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)

DOIFull Paper Access

47

Citations

0

References

2020

Year

Jaume Capdevila, Àlex Teulé, Carlos López, Rocio García‐Carbonero, Marta Benavent, Ana Custodio, Antonio Cubillo, Vicente Alonso, Teresa Alonso Gordoa, Alberto Carmona‐Bayonas,
Annals of Oncology

No additional data available for this publication yet. Check back later!